Walter M. Stadler to Ribonucleases
This is a "connection" page, showing publications Walter M. Stadler has written about Ribonucleases.
Connection Strength
0.045
-
A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer. Invest New Drugs. 2001; 19(3):255-60.
Score: 0.045